PD
Therapeutic Areas
Phlox Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RNA Therapy for Genetic Laminopathies | Cardiomyopathy due to LMNA mutations | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| RNA Therapy for Genetic Laminopathies | Cardiomyopathy due to LMNA mutations | Preclinical |